期刊文献+

扶阳泄浊化瘀法治疗溃疡性结肠炎探讨 被引量:9

Exploration of Reinforcing Yang,Purging Turbidity and Dispelling Blood Stasis Method in Treating Ulcerative Colitis
原文传递
导出
摘要 溃疡性结肠炎(UC)是一种慢性、反复发作的非特异性炎症性疾病,本病中医病机是以脾肾阳虚为本,湿、寒、热、痰、瘀等邪为标,病位在大肠,与脾、胃、肝、肾、肺相关,表现出本虚标实、寒热交错、阴阳失调、气机逆乱的特点。认为应以扶阳泄浊化瘀法治本,以扶脾肾之阳为基础,辅以通下泄浊、行气活血、化瘀止痛等治标。 Ulcerative colitis (UC) is a chronic repeated nonspecific inflammatory disease. The root cause is Yang deficiency of spleen and kidney, with the superficial pathogenic factors of dampness, cold, heat, phlegm, sta- sis, etc. Disease location is large intestine, relating to spleen, stomach, liver and lung. Expressed characteristics is root deficiency, superficial excess, mix of cold and heat, imbalance of Yin and Yang and Qi-movement disturbance. The author holds that reinforcing Yang, purging turbidity and dispelling blood stasis method should be applied to treat this disease. Based on reinforcing Yang of spleen and kidney, treat incidental factors by catharsis, purging turbidity, promoting Qi and blood circulation, dispelling blood stasis and analgesia.
出处 《中医杂志》 CSCD 北大核心 2015年第19期1641-1644,共4页 Journal of Traditional Chinese Medicine
关键词 溃疡性结肠炎 扶阳泄浊化瘀 本虚标实 ulcerative colitis reinforcing Yang, purging turbidity and dispelling blood stasis fundamental deficiency and incidental excess
  • 相关文献

参考文献10

二级参考文献45

  • 1陈灏珠,林果为.实用内科学[M].13版.北京:人民卫生出版社,2009:919.
  • 2McCARTHY J, O' MAHONY L, O' CALLAGHAN L, et al. Double blind,placebo controlled trial of two probiotic strains ininterleukin 10 knockout mice and mechanistic link with cytokine balance [ J ]. Gut, 2003,52(7) :975-980.
  • 3LLOPIS M, ANTOLIN M, GUARNER F, et al. Mucosal eolonisation with Lactobacillus casei mitigates barrier injury induced by exposure to trinitronbenzene sulphonic acid[ J ]. Gut ,2005,54 (7) :955-959.
  • 4REID G, BURTON J. Use of Lactobacillus to prevent infection by patho- genic bacteria[ J]. Microbes Infect,2002,4(3 ) :319-324.
  • 5DOTAN I, RACHMILEWITZ D. Probiotics in inflammatory bowel dis- ease: possible mechanisms of action [ J ]. Curt Opin Gastreenterul, 2005,21 (4) :426-430.
  • 6Di CARO S, TAO H, GRILLO A, et al. Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa[ J]. Dig Liver Dis, 2005,37 (5) :320-329.
  • 7MITSUYAMA K, TOMIYASU N, TAKAKI K, et al. Interleukin-10 in the pathophysiology of inflammatory bowel disease: increased serum concentrations during the recovery phase [ J ]. Mediators Inflamm, 2006,2006(6) :268-275.
  • 8KORZENIK J R, PODOLSKY D K. Evolving knowledge and therapy of in flammatory bowel disease [ J ]. Nat Rev Drug Diseov, 2006,5 (3) : 197-209.
  • 9RESTA-LENERT S, BARRETT K E. Live probiofies protect intestinal epithelial cells from the effects of infection with enteroinvasive Esche- richia coli (EIEC) [J]. Gut,2003,52(7) :988-997.
  • 10欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见[J].胃肠病学,2007,12(8):488-495. 被引量:751

共引文献433

同被引文献130

引证文献9

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部